Keywords: virologic, conduct, biomarker, trial, iressa, usa, signed

ViroLogic to conduct biomarker trial of Iressa

Article | 14 March 2005

Print This

The USA's ViroLogic has signed a deal with Anglo-Swedish drugmaker AstraZeneca to carry out a cancer biomarker study with application ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in